Hippo Pathway dysregulation is associated with a broad spectrum of cancers, and mutations in upstream component Merlin are associated with the familial tumor syndrome Neurofibromatosis Type 2 (NF2) [2–19]. The gene discussed is NF2; the disease is cancer.